Research status and challenges in the prognosis of primary biliary cholangitis after liver transplantation
DOI:10.3969/j.issn.1001-5256.2021.04.050
- VernacularTitle:原发性胆汁性胆管炎肝移植术后预后研究现状与挑战
- Author:
Lin CHEN
1
;
Ning LIU
;
Jinglan JIN
;
Yanjun CAI
;
Fang XU
;
Junqi NIU
;
Wanyu LI
Author Information
1. Department of Hepatology, The First Hospital of Jilin University, Changchun 130021, China
- Publication Type:Research Article
- Keywords:
Liver Cirrhosis, Biliary;
Liver Transplantation;
Prognosis;
TAURO-URSODESOXYCHOLIC ACID
- From:
Journal of Clinical Hepatology
2021;37(4):955-958
- CountryChina
- Language:Chinese
-
Abstract:
Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease with unknown etiology, and patients with poor response to ursodeoxycholic acid and obeticholic acid may eventually progress to liver cirrhosis and even liver failure. Liver transplantation is the only effective treatment method for PBC at present. This article elaborates on liver transplantation, survival time after liver transplantation, complications, recurrence of PBC after liver transplantation, and prospects and challenges of liver transplantation in patients with PBC, so as to provide a reference for clinical outcome and treatment after liver transplantation for PBC.
